pharmaphorum

FEBRUARY 4, 2021

A white paper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month.

Documentation 139

Documentation Communication 139

pharmaphorum

SEPTEMBER 18, 2020

The pharmaceutical industry is at an inflection point, where ground-breaking innovation must be translated into transformational value for patients, healthcare professionals and society. Meeting these challenges head-on needs new frameworks and a wide-ranging programme of internal transformations.

116

116

ISPE

AUGUST 1, 2023

In recent years, the reality of curative treatment and commercial approval of several autologous CAR-T products triggered developers to plan for increased capacity and treating larger patient populations. Download White Paper To download this white paper, complete the form below.

Communication 96

Communication 96

BioPharm

SEPTEMBER 25, 2023

Anything less impacts regulatory compliance, project timelines and—most importantly—patient safety. This white paper explores the specialized equipment, expertise, and services needed for efficient biologics fill/finish manufacturing.

40

40

pharmaphorum

NOVEMBER 20, 2020

Havas Lynx Group’s 2020 white paper provides a blueprint for pharma brands to inject meaning into their media. The latter is the subject of our 2020 white paper, Media Means Business. COVID-19 has left us more reliant on media than ever – both the pharma industry and society as a whole. What do we mean by ‘media’?

98

98

ISPE

FEBRUARY 1, 2023

 Determining the areas of the business process and/or system functionality that have a direct impact on patient safety, product quality, or system integrity will concentrate validation efforts to be clearly aligned to what needs to be tested. Download White Paper To download this white paper, complete the form below.

Documentation 98

Documentation Communication 98

pharmaphorum

NOVEMBER 9, 2021

The pandemic’s first effects on pharma sales were swift and immediate, as lockdowns were put in place and doctors did everything they could to avoid unnecessary face-to-face contact with patients and representatives. This white paper explains how to adjust to it. The industry faces the dawn of a new age in sales coaching.

Communication 97

Communication 97

ISPE

JULY 1, 2023

Introducing EU Annex 1: Understanding the Newest Regulatory Requirements Trudy Patterson Sat, 07/01/2023 - 06:00 White Paper — Sponsored Content Introducing EU Annex 1: Understanding the Newest Regulatory Requirements 1 July 2023 As its title implies, Annex 1 is the European guidance document for good manufacturing practices of medicinal products.

Documentation 52

Documentation Communication 52

pharmaphorum

OCTOBER 5, 2021

Since 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and patient outreach, to prepare for the wave of digitisation in the healthcare industry. Read: Transform patient experience with intelligent hyper-personalisation in full.

Pharmaceutical Companies 117

Pharmaceutical Companies Pharmaceutical Companies 117

pharmaphorum

OCTOBER 4, 2021

COVID-19 forced an unprecedented shift towards the virtual delivery of healthcare, suddenly compelling doctors increasingly to use digital means to care for their patients. As healthcare resources and delivery were prioritised, there was also a massive and ongoing impact on growing waiting lists and time-lags for diagnosis and treatment.

Communication 71

Communication 71

pharmaphorum

FEBRUARY 15, 2021

The overall aim of the alliance – which will see Healthware work alongside the NCI’s Pascale Hospital – is to develop digital health tools that will deliver “more precise and accessible treatments to patients”, said the partners in a statement.

Communication 95

Communication Hospitals 95

Pharma Marketing Network

JULY 19, 2023

This information could be valuable to potential patients who are considering taking the drug, and it could help the company attract new leads. For example, a pharmaceutical company could create a white paper about a particular medical condition.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

AUGUST 5, 2021

Health Union’s white paper, Beyond the Treatment, Making the HCP-Patient Relationship Work: A Study Uncovering the Patient Perspective , explores those relationships in detail. Furthermore, that thought process can be truly reductive of the hurdles patients may overcome to find a treatment plan that works for them.

Communication 98

Communication 98

Pharmaceutical Technology

DECEMBER 8, 2022

Directed against a cell membrane protein called CD19, Yescarta uses the immune system of the patient to destroy cancer. It is created by taking T cells from the patient’s blood and then engineered in the laboratory to express chimeric antigen receptors. . Optimise your cell therapy process: a guide to cell thawing.

Communication 122

Communication Immunization Hospitals 122

pharmaphorum

SEPTEMBER 1, 2021

The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians implemented during the acute phase of the pandemic, with a focus on the way in which treatment strategies were altered.

Patient Care 110

Patient Care 110

pharmaphorum

FEBRUARY 10, 2021

The recommendations for the Country’s pathway towards DTx are captured in the White Paper “Digital Therapeutics, an Opportunity for Italy” The official journal of the Smith Kline Foundation, Tendenze Nuove , published the White Paper “ Digital Therapeutics, an Opportunity for Italy ” on 13 January 2021.

Documentation 52

Documentation 52

ISPE

AUGUST 2, 2023

We see that life sciences organizations must evolve and transform their supply chain to deliver increased levels of resiliency, agility, and sustainability to meet the requirements of a modern business and serve the needs of patients. Download White Paper To download this white paper, complete the form below.

Communication 52

Communication 52

Pharmaceutical Technology

JANUARY 17, 2023

It could be used for T-Cell Acute Lymphoblastic Leukaemia (T-ALL) treatment in patients for whom bone marrow transplantation and chemotherapy failed to work. Dr Alvarez-Vallina said: “It is necessary to develop strategies addressed to very specific targets for each disease and adapted for each patient. STAb-T therapy is on this path.”.

Hospitals 110

Hospitals Chemotherapy Communication Immunization 110

Pharmaceutical Technology

DECEMBER 21, 2022

The vaccine manufacturing facility will also offer National Health Service (NHS) patients access to the company’s Covid-19 vaccines that can provide protection against various variants. Additionally, the centre is anticipated to have to capacity to make up to 250 million doses of vaccines per year.

Vaccines 140

Vaccines Communication 140

Pharmaceutical Technology

FEBRUARY 16, 2023

The MOS platform enables translational research on micro-tumours derived from patients with new capabilities. It enables quick evaluation of a patient tumour response to a range of cancer drug modalities within 14 days of obtaining harvested samples of tumour cells.

Communication 96

Communication 96

Pharmaceutical Technology

MARCH 8, 2023

The multi-year collaboration aims to develop new technologies which will help in improving clinical outcomes for patients. We are delighted to be partnering with the CAR T pioneers at Penn and believe that combining our expertise in science and technology will help bring the next generation of cell therapies to patients faster.”

Communication 97

Communication FDA 97

The Checkup by Singlecare

OCTOBER 26, 2023

Key takeaways: Low MCHC is a relatively common health condition that mostly affects women or black patients but can affect anyone regardless of age, sex, race, or ethnicity. A 2015 study showed that when compared to white patients, Asian and black patients displayed lower MCHC levels. Find updated low MCHC statistics.

Immunization 96

Immunization Hospitals 96

pharmaphorum

MARCH 10, 2021

A new focus on “place” and the introduction of medicines registers are among the proposals in a new government white paper on the future of NHS England. This is where the bulk of healthcare will be experienced by patients. Very few decisions will be taken at that level. Medicines registries. Opportunities abound.

Documentation 56

Documentation 56

Pharmaceutical Technology

MARCH 10, 2023

The representative expected the facility to open more treatment opportunities for UK citizens saying, “It will help give patients quick access to the latest treatments by increasing the number of UK patients with incurable diseases who are able to take part in clinical trials and bring new treatments into the NHS faster.”

Communication 105

Communication 105

Pharmaceutical Technology

NOVEMBER 29, 2022

With a shared mission of making cell therapies available to solid tumour patients, the capabilities of Neogene in TCR-T discovery, development and production will bolster the goal of AstraZeneca to transform patient outcomes. The takeover will offer AstraZeneca access to TCR-Ts, which possess the potential for fighting solid tumours.

Communication 111

Communication 111

Pharmaceutical Technology

DECEMBER 23, 2022

Typically carried out at the point of care, errors in cell therapy thawing could compromise treatment efficacy, leading to significant patient impact as well as high costs and a compromised reputation for the product’s developer. Optimise your cell therapy process: a guide to cell thawing.

Communication 131

Communication 131

Pharmaceutical Technology

FEBRUARY 9, 2023

ReviR combines computational and high throughput drug discovery technologies to deliver advanced medicines to patients. Our BindeR and SpliceR platform technologies have the potential to advance therapeutics for undruggable cancer targets, and we believe this collaboration will accelerate the discovery of new treatments for patients.”

Communication 96

Communication 96

Pharmaceutical Technology

MARCH 20, 2023

With this collaboration, we want to develop mRNA vaccine product candidates with the potential to improve the lives of patients who suffer from certain autoimmune diseases and allergies.” RVAC Medicines CEO Dr Sean Fu said: “We are excited to begin this collaboration with Dr Weissman, a pioneer in the field of mRNA vaccines and therapeutics.

Vaccines 98

Vaccines Immunization Communication 98

Pharmaceutical Technology

FEBRUARY 23, 2023

Free Whitepaper Optimise your cell therapy process: a guide to cell thawing Typically carried out at the point of care, errors in cell therapy thawing could compromise treatment efficacy, leading to significant patient impact as well as high costs and a compromised reputation for the product’s developer.

Vaccines 115

Vaccines Communication 115

pharmaphorum

AUGUST 24, 2022

It was compared in the study to an already-available free app – TMSOFT’s White Noise Lite – which is described by the researchers as “a popular self-help passive sound therapy app.” The results have just been published in the journal Frontiers in Neurology.

FDA 52

FDA 52

Pharmaceutical Technology

DECEMBER 12, 2022

Gilead company Kite has entered an international strategic partnership with Arcellx for the joint development and commercialisation of the latter’s T-cell therapy, CART-ddBCMA, to treat relapsed or refractory multiple myeloma patients. Most importantly, this collaboration is focused on accelerating access for patients in need.”.

Communication 105

Communication 105

pharmaphorum

APRIL 11, 2022

“The industry has concerns regarding the use of regulatory tools designed for medicines authorisation being applied to address availability issues that are within the remit of member states,” says the white paper. . — EFPIA (@EFPIA) April 11, 2022.

Documentation 52

Documentation Pharmaceutical Companies Pharmaceutical Companies 52

The FDA Law Blog

MARCH 1, 2023

Brevig, Senior Regulatory Device and Biologics Expert — In January 2023, FDA published a paper summarizing its lessons learned from two pilot Quality Management Maturity (QMM) Pilot Programs, such as best practices for conducting QMM assessments and developing the QMM scoring system. By Holly N.

Dosage 45

Dosage FDA 45

Pharmaceutical Technology

JANUARY 5, 2023

Prevail and Capsida are committed to developing highly effective and safe gene therapies that have the potential to be transformative for patients living with serious CNS diseases.”. According to the deal, Capsida will get $55m, comprising an upfront payment and a commitment to participate in its next funding round.

Communication 95

Communication 95

PQA

FEBRUARY 29, 2024

The burden and cost of treating rare disease is high for patients, our care system and society. Ensuring the quality of medication use is critically important for rare disease patients, payers, clinicians, specialty pharmacies and everyone with a role in the care process.

Specialty Pharmacies 45

Specialty Pharmacies Communication Patient Care 45

Pharmaceutical Technology

MARCH 28, 2023

This guide addresses how cell thawing has historically developed into the new techniques used today, along with the physical and biological implications of key metrics and components such as warming rate and ice structure.

Communication 94

Communication 94

Pharmaceutical Technology

DECEMBER 18, 2022

Typically carried out at the point of care, errors in cell therapy thawing could compromise treatment efficacy, leading to significant patient impact as well as high costs and a compromised reputation for the product’s developer. Optimise your cell therapy process: a guide to cell thawing.

Vaccines 121

Vaccines Communication 121